Strategic Partnerships Sanara MedTech emphasizes long-term strategic partnerships with focus on products that deliver efficacious outcomes at lower overall cost, presenting opportunities to position cost-effective, outcome-driven solutions to hospitals, clinics, and post-acute care settings.

High Growth Signals Recent news indicates revenue surpassing 100M and interest from potential acquirer MiMedx, suggesting rapid market traction and validation of the surgical wound care and regenerative medicine portfolio, which can be leveraged to engage expansion-focused buyers.

Product Pipeline In addition to current wound care and surgical products, Sanara is developing OsStic, a synthetic injectable bone bioadhesive with FDA breakthrough designation, offering a cross-sell opportunity to hospitals investing in regenerative and orthopedic solutions.

Key Executives Leadership includes a CEO with a background in building early commercial operations, providing a credible, sales-focused point of contact for strategic discussions, channel partnerships, and large-system sales conversations.

Tech & Enablement Tech stack includes marketing and analytics tools (LinkedIn Ads, The Trade Desk, HubSpot, Mailchimp) and enterprise systems (NetSuite, Shopify, WordPress), enabling scalable multi-channel outreach, CRM-driven nurturing, and streamlined procurement conversations with health care buyers.